ASCEND BY NTHRYS
Research Abroad Products

Immunotechnology Project Topics

Browse all focused areas across all project categories under this field.

Showing 1–12 of 200 project topics
Automated High-Throughput mAb Screening and Selection Platform
A cloud-connected automation platform that uses AI-driven image analysis and robotic cell handling to screen and select monoclonal antibodies at scale, reducing screening time from weeks to days. This accelerates time-to-market for therapeutic candidates and reduces R&D costs by 40-60%, enabling biotech companies to process multiple programs simultaneously.
Monoclonal Antibody Production Technology Platforms Click to view more details →
CHO and NSO Cell Line Engineering SaaS Dashboard
A comprehensive SaaS platform that optimizes CHO and NSO cell line development through predictive modeling, clone selection algorithms, and real-time bioreactor monitoring integration. Reduces cell line development timelines from 12-18 months to 6-9 months while improving final titers by 2-4 fold, directly increasing manufacturing output per facility.
Monoclonal Antibody Production Technology Platforms Click to view more details →
Next-Generation Hybridoma Technology with AI Fusion Prediction
An intelligent software-hardware system that predicts optimal B-cell and myeloma fusion pairs using machine learning, combined with microfluidic cell fusion devices for higher efficiency monoclonal antibody generation. Increases hybridoma success rates from 5-10% to 30-40%, reducing screening burden and accelerating antibody discovery for contract research organizations and pharma companies.
Monoclonal Antibody Production Technology Platforms Click to view more details →
Recombinant mAb Expression Platform with Modular Vector Libraries
A commercial expression system offering pre-validated mammalian and insect cell vector libraries optimized for mAb production with integrated GMP-grade plasmid manufacturing and quality control services. Enables rapid transition from discovery to manufacturing with 95% success rate and reduces expression optimization costs by 50%, appealing to smaller biotech and academic institutions.
Monoclonal Antibody Production Technology Platforms Click to view more details →
Real-Time mAb Quality Attributes and Potency Analytics Engine
An advanced analytics platform integrating mass spectrometry, SPR biosensors, and bioinformatics to provide real-time monitoring of mAb post-translational modifications, aggregation, and bioactivity during production. Reduces batch rejection rates by 25-35% and enables predictive maintenance scheduling, saving manufacturers millions in lost product annually.
Monoclonal Antibody Production Technology Platforms Click to view more details →
GMP-Compliant mAb Purification Process Development Software Suite
A digital workflow platform that designs, optimizes, and documents protein A, ion exchange, and hydrophobic interaction chromatography workflows with integrated regulatory compliance documentation and batch record generation. Accelerates purification method transfer from research to manufacturing by 60% and reduces compliance documentation errors, directly supporting faster regulatory submissions.
Monoclonal Antibody Production Technology Platforms Click to view more details →
Therapeutic mAb Manufacturability Prediction and De-Risking Platform
An AI-powered SaaS tool that predicts manufacturability challenges, expression levels, and purification difficulty from mAb sequences before cell line development begins, incorporating proprietary databases of 50,000+ antibodies. Reduces late-stage manufacturing failures by 70%, enabling pharma companies to de-risk programs early and allocate resources to viable candidates.
Monoclonal Antibody Production Technology Platforms Click to view more details →
Continuous mAb Production Bioprocess Automation and Control System
An end-to-end hardware and software platform for continuous perfusion bioreactors with integrated process analytical technology and machine learning-driven fed-batch optimization for monoclonal antibody manufacturing. Increases facility throughput by 3-5x compared to traditional batch processing while reducing facility footprint and utilities costs by 40%.
Monoclonal Antibody Production Technology Platforms Click to view more details →
mAb Therapeutic Candidate Benchmarking and Competitive Positioning Engine
A cloud-based intelligence platform aggregating clinical, manufacturing, and patent data to benchmark therapeutic mAb candidates against competitors in real-time, with market sizing and manufacturing cost modeling. Provides pharma companies with actionable strategic insights to guide portfolio selection and licensing decisions, reducing portfolio risk.
Monoclonal Antibody Production Technology Platforms Click to view more details →
Multispecific and Bispecific mAb Design and Expression Optimization Toolkit
A specialized software and services platform for designing, modeling, and optimizing bispecific and multispecific antibody constructs with validated expression strains and scale-up protocols. Enables faster development of complex next-generation mAbs with 3-5x higher success rates than manual approaches, capturing high-margin revenue from premium therapeutic programs.
Monoclonal Antibody Production Technology Platforms Click to view more details →
CAR-T Manufacturing Automation Platform for GMP Production
A software-controlled manufacturing platform that automates CAR-T cell engineering, expansion, and quality control workflows while maintaining FDA GMP compliance standards. This reduces production time by 40-60%, decreases manufacturing costs per dose, and enables contract manufacturers to scale commercial CAR-T production capacity.
CAR-T Cell Therapy Technology Development Click to view more details →
Real-time CAR-T Cell Potency and Viability Analytics Dashboard
A cloud-based analytics platform that integrates multi-parametric flow cytometry data to monitor CAR-T cell phenotype, functionality, and persistence metrics throughout manufacturing and post-infusion. This enables manufacturers and clinical teams to predict treatment outcomes, optimize batch release decisions, and justify premium pricing for superior quality lots.
CAR-T Cell Therapy Technology Development Click to view more details →